Amoy Diagnostics Co.,Ltd.’s Net Profit Rose 41.5% in First Half of 2023

Amoy Diagnostics Co.,Ltd. (厦门艾德生物医药科技股份有限公司) (300685.SZ) reported a net profit of 126.8 million yuan in the first half of 2023, up 41.5% year-on-year.

Meanwhile, the company posted 458.7 million yuan in revenue, up 16.9% year-on-year.

At the end of the reporting period, it had 1.7 billion yuan in total assets and 151.7 million yuan in total liabilities, with a liability-to-asset ratio of 8.9%.